
    
      This study is a prospective open-label, multicenter study for clinical follow-up of the
      ARGOS-01 and ARGOS-02 patients.

      From the ARGOS-01 to the ARGOS-02 study, some modifications were made to the form of the
      ARGOS-IO implant in consequence of the outcomes of the ARGOS-01 study.

      Maximal 5 patients of the ARGOS-01 study and maximal 21 patients of the ARGOS-02 study will
      take part in this study.

      The sensor was always implanted in one eye only which will be the study eye.
    
  